| scholarly article | Q13442814 |
| P50 | author | Daniela Parolaro | Q88928520 |
| P2093 | author name string | Daniela Viganò | |
| Tiziana Rubino | |||
| Daniela Braida | |||
| Mariaelvina Sala | |||
| Valeria Capurro | |||
| Alessia Zani | |||
| P2860 | cites work | Guide to Receptors and Channels (GRAC), 3rd edition | Q43088119 |
| Pattern of use and subjective effects of Salvia divinorum among recreational users. | Q43842086 | ||
| Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice | Q44119479 | ||
| Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study | Q44336066 | ||
| Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward | Q44336472 | ||
| The plant-derived hallucinogen, salvinorin A, produces ?-opioid agonist-like discriminative effects in rhesus monkeys | Q44343280 | ||
| Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats | Q44344204 | ||
| Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man. | Q44347638 | ||
| Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist | Q44351693 | ||
| Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase | Q44940981 | ||
| CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents | Q44977076 | ||
| Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. | Q46932814 | ||
| Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex | Q46962183 | ||
| Action of drugs of abuse on brain reward systems: an update with specific attention to opiates | Q48920199 | ||
| Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling | Q50113929 | ||
| Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats. | Q52026041 | ||
| Antidepressant effects of the herb Salvia divinorum: a case report. | Q55035594 | ||
| “Behavioural despair” in rats and mice: Strain differences and the effects of imipramine | Q67016807 | ||
| The tail suspension test: a new method for screening antidepressants in mice | Q69947780 | ||
| Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist | Q24535736 | ||
| Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses | Q24683322 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations | Q28238385 | ||
| Behavioral despair in mice: a primary screening test for antidepressants | Q28258027 | ||
| Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants | Q28271841 | ||
| Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.) | Q28275330 | ||
| The mesolimbic dopamine reward circuit in depression | Q28304016 | ||
| Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 | ||
| Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat | Q29619517 | ||
| Specificity in the projection patterns of accumbal core and shell in the rat. | Q30451154 | ||
| Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone | Q30481448 | ||
| Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement | Q33269030 | ||
| Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A | Q33973923 | ||
| Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors | Q33984723 | ||
| Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats | Q34185186 | ||
| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis | Q34234907 | ||
| Salvia divinorum and salvinorin A: new pharmacologic findings | Q34292784 | ||
| Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats | Q34459404 | ||
| Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice | Q34468303 | ||
| The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum | Q34478698 | ||
| Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. | Q34516240 | ||
| Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats | Q34682154 | ||
| Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor | Q35082154 | ||
| Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. | Q36977483 | ||
| A review of the validity and variability of the elevated plus-maze as an animal model of anxiety | Q41052733 | ||
| Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors | Q41832173 | ||
| Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. | Q42513159 | ||
| The use of a plus-maze to measure anxiety in the mouse | Q42653714 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salvia divinorum | Q320584 |
| P304 | page(s) | 844-53 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents | |
| P478 | volume | 157 |
| Q35837572 | A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats |
| Q57455107 | Age as a factor in stress and alcohol interactions: A critical role for the kappa opioid system |
| Q44343134 | Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats |
| Q30444312 | Animal models of serotonergic psychedelics |
| Q33595602 | Anti-depressant and anxiolytic potential of Acacia hydaspica R. Parker aerial parts extract: Modulation of brain antioxidant enzyme status |
| Q36286335 | Antidepressive and antinociceptive effects of ethanolic extract and fruticuline A from Salvia lachnostachys Benth leaves on rodents |
| Q42685211 | Antidepressive-Like Property of Dichloromethane Fraction of Pimenta pseudocaryophyllus and Relevance of Monoamine Metabolic Enzymes |
| Q92170256 | Antidiarrheal, vasorelaxant, and neuropharmacological actions of the diterpene tilifodiolide |
| Q46880304 | Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat. |
| Q52649152 | CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice. |
| Q48191152 | Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. |
| Q28275440 | Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity |
| Q47871946 | Depressant Effects of Salvia divinorum Involve Disruption of Physiological Sleep. |
| Q93079359 | Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist |
| Q34140370 | Endogenous opiates and behavior: 2009 |
| Q49827915 | Erinacine A-Enriched Hericium erinaceus Mycelium Produces Antidepressant-Like Effects through Modulating BDNF/PI3K/Akt/GSK-3β Signaling in Mice |
| Q98464765 | Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain |
| Q39761953 | Gut feelings about the endocannabinoid system |
| Q24631675 | Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines |
| Q26784030 | High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity |
| Q57476500 | Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents |
| Q28075656 | Kappa Opioids, Salvinorin A and Major Depressive Disorder |
| Q34453709 | Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents |
| Q35736840 | Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment |
| Q34632744 | Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats. |
| Q50695065 | Mining mouse behavior for patterns predicting psychiatric drug classification. |
| Q39288326 | Modulation of serotonin transporter function by kappa-opioid receptor ligands |
| Q38778876 | Molecular Signaling Pathways Behind the Biological Effects of Salvia Species Diterpenes in Neuropharmacology and Cardiology |
| Q30467220 | Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A |
| Q37987431 | Pharmacological activity of salvinorin A, the major component of Salvia divinorum |
| Q34939810 | Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A |
| Q34545917 | Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects |
| Q44641835 | Salvia divinorum use and phenomenology: results from an online survey |
| Q38652778 | Salvia divinorum: An overview of the usage, misuse, and addiction processes |
| Q90191903 | Salvinorin A Does Not Affect Seizure Threshold in Mice |
| Q28481482 | Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets |
| Q34401390 | Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse. |
| Q35799306 | Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxic/ischemic injury via extracellular signal-regulated kinase/mitogen-activated protein kinase in piglets |
| Q36069379 | Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, κ receptor, and adenosine triphosphate-sensitive potassium channel. |
| Q42411070 | Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection |
| Q49629222 | Salvinorin A reduces neuropathic nociception in the insular cortex of the rat. |
| Q26776241 | Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development |
| Q59131915 | Stress alters social behavior and sensitivity to pharmacological activation of kappa opioid receptors in an age-specific manner in Sprague Dawley rats |
| Q100428072 | The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain |
| Q47878237 | The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects. |
| Q34305078 | The active alkaloids of Gelsemium elegans Benth. are potent anxiolytics |
| Q47977698 | The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice. |
| Q47433117 | The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice |
| Q37946259 | The dynorphin/κ-opioid receptor system and its role in psychiatric disorders |
| Q36287728 | The role of the dynorphin/κ opioid receptor system in anxiety |
| Q60686096 | Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo |
Search more.